Is the day of the zombie biotech coming to an end? Eyes have it: Peninsula biotech focuses on glaucoma, more in big test Eyes ...

The mood is better than the numbers suggest. The doom-loop panic of March and April is behind us, even though the XBI has ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

In the July 2 release, 4DMT explained that the 25% layoffs are part of a move to “streamline operations to offset additional ...

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...

Bioo CEO Pablo Vidarte says his bioluminescent landscaping will arrive in Dubai within months, following successful ...

Between Casgevy's long-term potential and the company's innovative pipeline, CRISPR Therapeutics could eventually recover and ...

The head of the EU's pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, ...

The startup aims to provide every life sciences expert with their team of intelligent agents, reducing response timelines for ...

Top Create Biotech has filed for an initial public offering. The biotechnology company said Wednesday that it intends to list shares under the ticker symbol TCBG on the Nasdaq Capital Market. Top ...

Primo Biotechnology Secures A Funding and Targets 2026 IPO To enhance strengthen global radiopharmaceutical strategy and ...